Primary Site >> Liver Cancer
Gene >> BSG
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. PMID: 15452378 |
Ref: Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. PMID: 15770719 |
Ref: Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. PMID: 16978202 |
Ref: Useful detection of CD147 (EMMPRIN) for pathological diagnosis of early hepatocellular carcinoma in needle biopsy samples. PMID: 17589939 |
Ref: [EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]. PMID: 18688595 |
Ref: A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera. PMID: 20199151 |
Ref: CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma. PMID: 22931464 |
Ref: An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma. PMID: 23182495 |
Ref: The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature. PMID: 25268615 |
Ref: Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN. PMID: 26054676 |
Ref: Cytoplasmic fragment of CD147 generated by regulated intramembrane proteolysis contributes to HCC by promoting autophagy. PMID: 28703811 |